Shell plc (NYSE:SHEL) is considering selling its U.S. chemicals business, with potential buyers including ExxonMobil, LyondellBasell, Apollo and the chemicals arm of Kuwait Petroleum Corporation. The assets could fetch as much as $8 billion, although the bids are still non-binding and there is no guarantee a deal will happen.
The potential sale would mark a major strategic shift. Shell plc (NYSE:SHEL) has invested heavily in its chemicals operations, including $14 billion in the Monaca, Pennsylvania complex, which can produce up to 1.6 million tonnes of polymers annually. Selling the broader U.S. portfolio for up to $8 billion would therefore mean accepting a substantial discount to invested capital.
The move fits CEO Wael Sawan’s broader strategy of directing capital toward businesses where Shell believes it can generate better returns. Shell has previously identified roughly $45 billion of capital in chemicals and renewables as underperforming and said it did not consider itself the “natural owner” of its chemicals portfolio.
Bull Case
The biggest positive for Shell plc (NYSE:SHEL) is capital discipline. Rather than continuing to pour money into a chemicals business that has historically struggled to generate attractive returns, Shell can potentially monetize the assets and redirect capital toward higher-return oil, gas and LNG opportunities. The presence of several interested buyers also gives Shell some negotiating leverage, particularly if bidders compete for the most attractive facilities.
The divestment also fits with Shell’s recent earnings momentum. The company generated $9.84 billion of net profit in the second quarter of 2026, more than double the year-earlier figure and its second-highest quarterly profit on record. Strong oil and gas prices, LNG and trading activity helped drive the result, while net debt fell to $41.8 billion and gearing declined to 18.7%.
A successful chemicals sale could therefore reinforce the market’s view of Shell plc (NYSE:SHEL) as a more focused energy company rather than a conglomerate spread across too many businesses. The company is already moving in this direction, including its agreement to acquire Canadian shale producer ARC Resources for $16.4 billion, its largest acquisition in a decade.
There is also a potential valuation benefit. Even though an $8 billion sale would be well below Shell’s historical investment, turning an underperforming asset into cash can still be value-accretive if the proceeds are redeployed into businesses generating higher returns. For shareholders, the key question is not how much Shell originally invested, but what return the assets can generate going forward.
Bear Case
The biggest concern is that Shell plc (NYSE:SHEL) could be selling a potentially valuable long-term business at the wrong time. Chemicals demand is expected to remain relatively resilient even as transportation fuel demand faces structural pressure from electric vehicles. In fact, chemicals could consume an increasing share of global oil and gas demand over time.
That makes Shell’s proposed exit somewhat uncomfortable strategically. Competitors such as ExxonMobil, Chevron, Saudi Aramco, and Adnoc have been expanding or considering greater exposure to chemicals precisely because they want to capture more value from crude and natural gas all the way through to plastics and other chemical products. If Shell sells now and chemicals margins recover structurally, it could ultimately regret giving up those assets.
The potential $8 billion valuation is another major issue. Shell has invested $14 billion in the Monaca facility alone, meaning the proceeds from the entire U.S. portfolio could represent a significant destruction of capital relative to historical investment. That does not necessarily mean the sale is economically wrong, but it highlights how poorly the chemicals strategy has performed.
There is also execution risk. The offers are non-binding, and a transaction may never materialize. Even if Shell reaches a deal, buyers could push for lower prices given the assets’ previous financial performance. Shell plc (NYSE:SHEL) itself had previously indicated that it wanted to be patient rather than sell during the bottom of the chemicals cycle.
Finally, Shell is becoming increasingly dependent on its core oil, gas and trading businesses. Its recent earnings have been exceptionally strong, but some of that strength has come from geopolitical volatility and unusually favorable trading conditions. Reuters reported that Shell’s second-quarter performance benefited significantly from higher energy prices and market disruption. If those conditions normalize, Shell will need its upstream and LNG investments to deliver sustainable returns.
Conclusion
For Shell plc (NYSE:SHEL), the potential chemicals divestment is more strategically positive than negative, provided management gets a reasonable price and uses the proceeds wisely. The sale would allow Shell to exit a business that has consumed significant capital without consistently generating attractive returns and concentrate resources on oil, gas, LNG and trading, where its recent financial performance has been much stronger.
The main drawback is the possibility that Shell is selling a strategically valuable business at a steep discount just as chemicals demand could become more important to the energy industry. The reported $8 billion valuation also underscores the poor returns on Shell’s past chemicals investments.
Overall, the news supports the bull case for Shell’s capital discipline and portfolio simplification, but investors should watch the final sale price closely. A transaction near the upper end of the reported range, followed by debt reduction, buybacks, or investment in high-return upstream/LNG projects, would be a meaningful positive. A much lower price would raise questions about whether Shell is crystallizing losses simply to accelerate its strategic refocus.
READ NEXT: Tesla (TSLA)’s Solar Roof Shutdown Raises Questions About its Energy Ambitions and UPS Builds for Future Growth With $2 Billion Global Logistics Investment
Disclosure: None. This article is originally published at Insider Monkey.
Hedge Fund Resource Center